NET PROFIT (x1000 NOK)
EMPLOYEES
ERCO Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-3,059
|
-4,701
|
-3,313 |
EBITDA |
-3,022
|
-4,666
|
-3,096 |
Total assets |
112
|
1,088
|
260 |
Current assets |
112
|
1,053
|
188 |
Current liabilities |
57
|
1,039
|
210 |
Equity capital |
56
|
49
|
51 |
- share capital |
51
|
47
|
49 |
Employees (average) |
2
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
50.0%
|
4.5%
|
19.6% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-2731.2%
|
-432.1%
|
-1274.2% |
Current ratio |
196.5%
|
101.3%
|
89.5% |
Return on equity (ROE) |
-5462.5%
|
-9593.9%
|
-6496.1% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-33%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.